Trials / Completed
CompletedNCT06457061
Evaluation of Caregiver Burden and Depression Severity in Patients With Hemiplegia
Evaluation of Caregiver Burden and Depression Severity in Patients With Right and Left Hemiplegia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Abant Izzet Baysal University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to evaluate the caregiving burden and severity of depression in patients with right hemiplegia and left hemiplegia.
Detailed description
Stroke is a disease characterized by neurological symptoms and signs lasting more than 24 hours, which can lead to death after the interruption of brain blood flow or due to focal brain damage. Post-stroke disability affects the patient's quality of life, makes the patient dependent on the caregiver, creates a caregiver burden, and brings socioeconomic and social consequences. Different hemispheres of the brain undertake different tasks. Different clinical conditions may occur in stroke patients with right or left hemiplegia following cerebrovascular infarction. This may affect the care burden of caregivers and the severity of depression. It was thought that knowing the care burden of patients with right and left hemiplegia would positively contribute to the quality of care given to patients.This study aimed to evaluate the caregiving burden and severity of depression in patients with right hemiplegia and left hemiplegia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Survey Study | Barthel Index for Activities of Daily Living Scale, Beck Depression Inventory and Star Cancellation Test questionnaires were applied to hemiplegia patients. Beck Depression Inventory and Zarit Caregiver Burden Interview surveys were administered to caregivers. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-04-01
- Completion
- 2024-05-01
- First posted
- 2024-06-13
- Last updated
- 2024-06-13
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06457061. Inclusion in this directory is not an endorsement.